机构

• 长春应用化学研究所 [5]
• 上海药物研究所 [1]

采集方式

• OAI收割 [6]

内容类型

• 期刊论文 [6]

发表日期

• 2018 [1]
• 2013 [2]
• 2012 [3]

学科主题

筛选

浏览/检索结果: 共6条，第1-6条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Design, Syntheses and Anticancer Activities of Platinum(IV) Prodrugs with Dihydrogen Phosphate as an Axial Ligand 期刊论文  OAI收割 CHINESE JOURNAL OF INORGANIC CHEMISTRY, 2018, 卷号: 34, 期号: 9, 页码: 1649-1654 作者:  Gao An-Li;  Xiong Qing-Feng;  Jiang Jing;  Yu Juan;  Lou Li-Guang   |  收藏  |  浏览/下载：45/0  |  提交时间：2019/01/08 platinum(IV) complexes  synthesis  characterization  anticancer activity   A cross-linked polymeric micellar delivery system for cisplatin(IV) complex 期刊论文  OAI收割 european journal of pharmaceutics and biopharmaceutics, 2013, 卷号: 83, 期号: 1, 页码: 63-75 Song HQ; Wang R; Xiao HH; Cai HD; Zhang WJ; Xie ZG; Huang YB; Jing XB; Liu TJ 收藏  |  浏览/下载：22/0  |  提交时间：2014/04/18 BIODEGRADABLE NANOPARTICLES  PLATINUM(IV) COMPLEXES  DRUG-DELIVERY  CELL-LINES  REDUCTION  GLUTATHIONE  MECHANISM  KINETICS  PACLITAXEL  CHEMISTRY   Multifunctional Pt(IV) pro-drug and its micellar platform: to kill two birds with one stone 期刊论文  OAI收割 journal of materials chemistry b, 2013, 卷号: 1, 期号: 6, 页码: 762-772 Song HQ; Xiao HH; Zhang Y; Cai HD; Wang R; Zheng YH; Huang YB; Li YX; Xie ZG; Liu TJ; Jing XB 收藏  |  浏览/下载：18/0  |  提交时间：2014/04/18 PLATINUM(IV) COMPLEXES  CISPLATIN  CANCER  DICHLOROACETATE  PHARMACOKINETICS  NANOPARTICLES  MITOCHONDRIA  RESISTANCE  REDUCTION  MECHANISM   Co-delivery of all-trans-retinoic-acid and cisplatin(IV) prodrug based on polymer-drug conjugates for enhanced efficacy and safety 期刊论文  OAI收割 journal of materials chemistry, 2012, 卷号: 22, 期号: 48, 页码: 25453-25462 Wang R; Xiao HH; Song HQ; Zhang Y; Hu XL; Xie ZG; Huang YB; Jing XB; Li YX 收藏  |  浏览/下载：16/0  |  提交时间：2013/06/09 ACUTE PROMYELOCYTIC LEUKEMIA  COMBINATION CHEMOTHERAPY  PLATINUM(IV) COMPLEXES  CANCER-CHEMOTHERAPY  MICELLES  CELLS  DOXORUBICIN  GLUTATHIONE  DIFFERENTIATION  NANOPARTICLES   The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy 期刊论文  OAI收割 biomaterials, 2012, 卷号: 33, 期号: 33, 页码: 8657-8669 Xiao HH; Song HQ; Zhang Y; Qi RG; Wang R; Xie ZG; Huang YB; Li YX; Wu Y; Jing XB 收藏  |  浏览/下载：21/0  |  提交时间：2013/04/22 CONFORMATIONAL-CHANGES  BIS(PLATINUM) COMPLEXES  BIODEGRADABLE POLYMER  ANTICANCER AGENTS  DNA-BINDING  PHASE-I  TRINUCLEAR  CARBOXYLATION  CISPLATIN(IV)  CYTOTOXICITY   Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy 期刊论文  OAI收割 journal of controlled release, 2012, 卷号: 163, 期号: 3, 页码: 304-314 Xiao HH; Li WL; Qi RG; Yan LS; Wang R; Liu S; Zheng YH; Xie ZG; Huang YB; Jing XB 收藏  |  浏览/下载：23/0  |  提交时间：2013/03/18 PLATINUM(IV) COMPLEXES  ANTICANCER DRUGS  DAUNORUBICIN CARDIOTOXICITY  ENDOMETRIAL CARCINOMA  OVARIAN-CANCER  PHASE-III  CISPLATIN  DOXORUBICIN  GLUTATHIONE  REDUCTION